AFAVX
Price
$14.91
Change
-$0.08 (-0.53%)
Updated
Sep 20 closing price
VEXMX
Price
$137.86
Change
-$1.00 (-0.72%)
Updated
Sep 20 closing price
Ad is loading...

AFAVX vs VEXMX

Header iconAFAVX vs VEXMX Comparison
Open Charts AFAVX vs VEXMXBanner chart's image
AMG River Road Focused Absolute Value I
Price$14.91
Change-$0.08 (-0.53%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Investor
Price$137.86
Change-$1.00 (-0.72%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AFAVX vs VEXMX Comparison Chart
Loading...
VS
AFAVX vs. VEXMX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFAVX is a Buy and VEXMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 107B vs. AFAVX (50.3M). AFAVX pays higher dividends than VEXMX: AFAVX (1.15) vs VEXMX (1.09). AFAVX was incepted earlier than VEXMX: AFAVX (9 years) vs VEXMX (37 years). AFAVX is a more actively managed with annual turnover of: 63.00 vs. VEXMX (11.00). VEXMX has a lower initial minimum investment than AFAVX: VEXMX (3000) vs AFAVX (100000). VEXMX annual gain was more profitable for investors over the last year : 22.52 vs. AFAVX (20.79). VEXMX return over 5 years is better than : 53.47 vs. AFAVX (21.82).
AFAVXVEXMXAFAVX / VEXMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years37 years-
Gain YTD16.1729.227175%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets50.3M107B0%
Annual Yield % from dividends1.151.09106%
Returns for 1 year20.7922.5292%
Returns for 3 years3.42-3.74-91%
Returns for 5 years21.8253.4741%
Returns for 10 yearsN/A116.67-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JACK44.150.52
+1.19%
Jack In The Box
RYTM53.640.47
+0.88%
Rhythm Pharmaceuticals
OMC102.610.88
+0.87%
Omnicom Group
IMNN1.14N/A
N/A
Imunon
ALIM5.54N/A
N/A
Alimera Sciences